Assignee
ELYSIUM HEALTH INC
US·11 granted patents·11 pending applications·8 citations·filing 2016–2023
Top patents by PatentIndex Score
22 records- 0189US12043616B2Crystalline forms of nicotinamide riboside chlorideELYSIUM HEALTH INC·Filed 2022·Granted Jul 23, 2024·2 cites·20 claims
- 0283US11260069B2Nicotinamide riboside and pterostilbene compositions and methods for treatment of neurodegenerative disordersELYSIUM HEALTH INC·Filed 2017·Granted Mar 1, 2022·2 cites·10 claims
- 0382US11414407B2Crystalline forms of nicotinamide riboside chlorideELYSIUM HEALTH INC·Filed 2018·Granted Aug 16, 2022·2 cites·14 claims
- 0477US11389468B2Nicotinamide riboside for use in treating or preventing liver damageELYSIUM HEALTH INC·Filed 2018·Granted Jul 19, 2022·1 cites·10 claims
- 0570US12128060B2Nicotinamide riboside for use in treating or preventing liver damageELYSIUM HEALTH INC·Filed 2022·Granted Oct 29, 2024·0 cites·8 claims
- 0670US11426398B2Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disordersELYSIUM HEALTH INC·Filed 2016·Granted Aug 30, 2022·1 cites·3 claims
- 0769US11998561B2Nicotinamide riboside and pterostilbene compositions and methods for treatment of neurodegenerative disordersELYSIUM HEALTH INC·Filed 2022·Granted Jun 4, 2024·0 cites·19 claims
- 0869US2023348521A1Methods of synthesizing nicotinamide ribosideELYSIUM HEALTH INC·Filed 2023·Application pending·0 cites
- 0968US12109206B2Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disordersELYSIUM HEALTH INC·Filed 2022·Granted Oct 8, 2024·0 cites·6 claims
- 1063US2025171482A1Deacylation of carbohydrate compoundsELYSIUM HEALTH INC·Filed 2023·Application pending·0 cites
- 1162US2025127804A1Ribose linkers and conjugates thereofELYSIUM HEALTH INC·Filed 2023·Application pending·0 cites
- 1260US2024415862A1Methods for treatment of menopausal syndromesELYSIUM HEALTH INC·Filed 2022·Application pending·0 cites
- 1357US11629163B2Methods of synthesizing nicotinamide ribosideELYSIUM HEALTH INC·Filed 2018·Granted Apr 18, 2023·0 cites·5 claims
- 1456US11129843B2Treating and preventing kidney damageELYSIUM HEALTH INC·Filed 2018·Granted Sep 28, 2021·0 cites·45 claims
- 1548US2020261483A1Methods and compositions for treating cystic fibrosisELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 1647US2021177875A1Methods and compositions for treating childhood or teen obesityELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 1747US2021186996A1Methods and compositions for treating multiple sclerosisELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 1845US2020085849A1Methods and compositions for improving sleepELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 1941US2020330496A1Methods and compositions for treating premature aging diseasesELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 2041US2020384004A1Methods and compositions for treating glaucomaELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 2141US2020330497A1Prevention and treatment of tdp-43 associated diseasesELYSIUM HEALTH INC·Filed 2018·Application pending·0 cites
- 2238US11730751B2Treating and preventing motor neuron diseases using nicotinamide ribosideELYSIUM HEALTH INC·Filed 2018·Granted Aug 22, 2023·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when ELYSIUM HEALTH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →